Daily Dose - Jan 2nd, 2025
Daily Dose |
View online
January 2, 2025
Building a more resilient biopharma supply chain in 2025
The biopharmaceutical industry’s supply chain will again be strained. Here’s how the sector could build more resiliency.
Read More
Roche, Innovent ink potential $1B ADC partnership
Innovent will receive an upfront payment of $80 million and is eligible for up to $1 billion in milestone payments, along with royalties on future sales.
Read More
Avid Bioservices’ $1.1B all-cash deal to go private appears on track
The biologics CDMO announced the expiration of the Hart-Scott-Rodino waiting period for its pending $1.1 billion acquisition by GHO and Ampersand.
Read More
